Deborah Baron

Deborah Baron

Direktör/Styrelseledamot på CEREVEL THERAPEUTICS HOLDINGS, INC.
57 år
Health Technology
Finance
Consumer Services

Profil

Deborah Baron is currently Chief Executive Officer at Amplyx Pharmaceuticals, Inc., Director at Seagen, Inc. since 2023, Independent Director at Cerevel Therapeutics Holdings, Inc. since 2021, Director at Cerevel Therapeutics, Inc., Director at Metsera, Inc. starting in 2025, and President at Encysive Pharmaceuticals, Inc. Former roles include Director at Global Blood Therapeutics, Inc., President & Director at Trillium Therapeutics, Inc., and Senior VP-Worldwide Business Development at Pfizer Inc. Education includes undergraduate studies at Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.

Aktiva positioner av Deborah Baron

FöretagPositionStart
CEREVEL THERAPEUTICS HOLDINGS, INC. Direktör/Styrelseledamot 2021-01-20
SEAGEN INC. Direktör/Styrelseledamot 2023-12-14
Verkställande Direktör -
Direktör/Styrelseledamot -
President -

Tidigare kända positioner av Deborah Baron

FöretagPositionSlut
TRILLIUM THERAPEUTICS President -
GLOBAL BLOOD THERAPEUTICS, INC. Direktör/Styrelseledamot -
PFIZER INC. Företagsledare/Principal -
Se detaljerna i Deborah Barons erfarenhet

Deborah Barons utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

14

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Deborah Baron